- Filed
- May 12, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 8, 2026 | 13.71M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 13.64M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 13.48M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $21K |
| Capex restated | Q1 2026 · Mar 31, 2025 | $117K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $19.71M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$21.61M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $96.95M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $163.4M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $196.61M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $193.2M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $177.36M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $173.72M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $702.83M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $783.94M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $899.44M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $977.14M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.20 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.23 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.21 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.24 |
| Net Income | Q1 2026 · Mar 31, 2026 | $2.74M |
| Net Income | Q1 2026 · Mar 31, 2025 | $3.19M |